Bausch + Lomb Corporation (BLCO)
TSX
Closed
Oct 7, 2026
Day's Range
24.5652 wk Range
19.36Overview - BLCO - Bausch + Lomb Corporation
Key Statistics
Valuation
Enterprise Value
18.94B
P/E (Trailing)
‪-23.52‬
P/E (Forward)
‪15.27‬
PEG Ratio
‪0.30‬
Price / Sales (TTM)
‪1.61‬
Price / Book
‪0.93‬
EV / EBITDA
‪16.40‬
Profitability
Gross Margin
‪62.19%‬
Profit Margin
‪-3.21%‬
Operating Margin
‪7.74%‬
Return on Assets
‪1.82%‬
Return on Equity
‪-2.51%‬
Ownership
Shares Outstanding
357.05M
Float
45.50M
Short % of Shares Outstanding
‪0.16%‬
Held by Insiders
‪87.29%‬
Held by Institutions
‪11.14%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪23.65‬
200-Day Avg
‪22.98‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Market Cap - BLCO - Bausch + Lomb Corporation
Peers - BLCO - Bausch + Lomb Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on TSX.
Profile Summary - BLCO - Bausch + Lomb Corporation
About
Bausch + Lomb Corporation is a global eye health company that develops, manufactures, and markets products for vision care, surgical care, and ophthalmic pharmaceuticals. Bausch + Lomb offers contact lenses, lens care solutions, eye drops, vitamins and supplements, and prescription therapies for a range of eye…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
